The 5-hydroxytryptamine2A receptor antagonist sarpogrelate hydrochloride inhibits acute platelet aggregation in injured endothelium

Journal of International Medical Research

Volumn 34, Issue 1, 2006, Pages 65-72

  Houkin, K ^a   Nakayama, N ^b   Nonaka, T ^a   Koyanagi, I ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Factor VIII; Intimal injury; Platelet aggregation; Sarpogrelate hydrochloride; Scanning electron microscopy

Indexed keywords

BLOOD CLOTTING FACTOR 7; SARPOGRELATE; SEROTONIN 2A ANTAGONIST; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 8; SEROTONIN; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SUCCINIC ACID DERIVATIVE;

ACUTE DISEASE; ANEURYSM CLIP; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTERY INTIMA; ARTERY SURGERY; ARTICLE; CAROTID ARTERY INJURY; COMMON CAROTID ARTERY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG INDICATION; ENDOTHELIUM INJURY; ENDOVASCULAR SURGERY; HEART MUSCLE ISCHEMIA; IMMUNOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE AGGREGATION INHIBITION; ANIMAL; DRUG ADMINISTRATION; ENDOTHELIUM; IMMUNOHISTOCHEMISTRY; INJURY; INTIMA; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; CAROTID ARTERY, COMMON; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIUM; FACTOR VIII; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MALE; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SUCCINATES; TUNICA INTIMA;

EID: 33645285271     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000603400108     Document Type: Article

References (23)

1. Ashford TP, Freiman DG: Platelet aggregation at sites of minimal endothelial injury. An electron microscopic study. Am J Pathol 1968; 53: 599-607.
2. Barradas MA, Gill DS, Fonseca VA, Mikhailidis DP, Dandona P: Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur J Clin Invest 1988; 18: 399-404.
3. Murakami Y, Ishinaga Y, Sano K, Murakami R, Kinoshita Y, Kitamura J, et al: Increased serotonin release across the coronary bed during a nonischemic interval in patients with vasospastic angina. Clin Cardiol 1996; 19: 473-476.
4. Leosco D, Fineschi M, Pierli C, Fiaschi A, Ferrara N, Bianco S, et al: Intracoronary serotonin release after high-pressure coronary stenting. Am J Cardiol 1999; 84: 1317-1322.
5. de Clerck FF, Janssen PA: Amplification mechanisms in platelet activation and arterial thrombosis. J Hypertens Suppl 1990; 8: S87-S93.
6. 2-receptor antagonist. Agents Actions 1982; 12: 388-397.
7. Doggrell SA: Sarpogrelate: cardiovascular and renal clinical potential. Expert Opin Investig Drugs 2004; 13: 865-874.
8. Hara H, Osakabe M, Kitajima A, Tamao Y, Kikumoto R: MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist. Thromb Haemost 1991; 65: 415-420.
9. Qi R, Ozaki Y, Satoh K, Kurota K, Asazuma N, Yatomi Y, et al: Quantitative measurement of various 5-HT receptor antagonists on platelet activation induced by serotonin. Thromb Res 1996; 81: 43-54.
10. Malyszko J, Pawlak K, Malyszko S, Mysliwiec M, Takada Y, Takada A: MCI-9042 and aggregation of uremic and normal platelets. J Serotonin Res 1996; 4: 251-258.
11. Nakamura K, Kariyazono H, Moriyama Y, Toyohira H, Kubo H, Yotsumoto G, et al: Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin. Blood Coagul Fibrinolysis 1999; 10: 513-519.
12. Nakamura K, Kariyazono H, Masuda H, Sakata R, Yamada K: Effects of sarpogrelate hydrochloride on adenosine diphosphate- or collagen-induced platelet responses in arteriosclerosis obliterans. Blood Coagul Fibrinolysis 2001; 12: 391-397.
13. Kuroda S, Kamiyama H, Abe H, Houkin K, Isobe M, Mitsumori K: Acetazolamide test in detecting reduced cerebral perfusion reserve and predicting long-term prognosis in patients with internal carotid artery occlusion. Neurosurgery 1993; 32: 912-918; discussion 918-919.
14. Dujovny M, Osgood CP, Barrionuevo PJ, Perlin A, Kossovsky N: SEM evaluation of endothelial damage following temporary middle cerebral artery occlusion in dogs. J Neurosurg 1978; 48: 42-48.
15. Tsukahara T, Yonekawa Y, Yamamoto M, Kaku Y, Ogata N, Taniguchi T: Regeneration of the rat carotid artery after clipping injury. Part I. A morphological study. Neurosurgery 1993; 32: 66-71; discussion 71-72.
16. Dujovny M, Kossovsky N, Laha RK, Leff L, Wackenhut N, Perlin A: Temporary microvascular clips. Neurosurgery 1979; 5: 456-463.
17. Thurston JB, Buncke HJ, Chater NL, Weinstein PR: A scanning electron microscopy study of micro-arterial damage and repair. Plast Reconstr Surg 1976; 57: 197-203.
18. Tani K, Kubota T, Yamashima T, Ito H, Yamamoto S: Ultrastructural study of arterial endothelial cells after temporary clipping (in Japanese). Neurol Med Chir (Tokyo) 1988; 28: 109-116.
19. Schror K: Antiplatelet drugs. A comparative review. Drugs 1995; 50: 7-28.
20. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al: International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994; 46: 157-203.
21. 2A) receptors. Cardiovasc Drug Rev 1997; 15: 101-121.
22. 2 serotonergic receptor in the platelet membrane by sarpogrelate hydrochloride and its metabolite (in Japanese, English abstract). Yakugaku Zasshi 1999; 119: 850-860.
23. Hara H, Shimada H, Kitajima A, Tamao Y: Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenyl)phenoxy]methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease. Arzneimittelforschung 1991; 41: 616-620.